Kevin McCulloch sold $723K of Xeris Biopharma (XERS)

Executed Jul 1, disclosed Jul 2, 1 day later.

Value, as filed

$723K

90,000 sh × $8.03

Executed

Jul 1

the trade date, as filed

Disclosed

Jul 2

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KM Kevin McCulloch See Remarks profile →

Kevin McCulloch (See Remarks) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $723K of XERS (90,000 sh × $8.03, as filed), executed Jul 1.

The name

XERS Xeris Biopharma Holdings, Inc. XERS · Healthcare · 26 filings in 24 months ticker →

Healthcare · Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chron…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kevin McCulloch in XERS

XERSSALE Xeris Biopharma Holdings, Inc. $127K
15,000 sh × $8.49
Exec Sep 1
Filed Sep 1 · 6:21 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $120K
15,000 sh × $8.02
Exec Aug 3
Filed Aug 4 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. $120K
15,000 sh × $8.00
Exec Jan 8
Filed Jan 9 · 5:30 PM ET XERSPURCHASE Xeris Biopharma Holdings, Inc. $110K
25,000 sh × $4.38
Exec Jun 13 2025
Filed Jun 16 2025 · 5:30 PM ET